Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | AOC1 | P19801 | 2/20 | 0.48 |
| ▸ | PADI4 | Q9UM07 | 1/20 | 0.45 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.41 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cis-Urocanic Acid SCHEMBL338885 | 1.00 | CYP3A4 (1.00) | CYP3A4TSHRKDM4EBLMNPSR1 | |
| Cis-Urocanic Acid SCHEMBL12963908 | 1.00 | CYP3A4 (1.00) | CYP3A4TSHRKDM4EBLMNPSR1 | |
| SCHEMBL15668642 | 0.82 | CYP3A4 (0.70) | CYP3A4TSHRKDM4EBLMNPSR1 | |
| SCHEMBL23749602 | 0.82 | CYP3A4 (0.70) | CYP3A4TSHRKDM4EBLMNPSR1 | |
| SCHEMBL8086657 | 0.79 | — | — | |
| SCHEMBL8552929 | 0.78 | KMT2A (1.00) | CYP3A4TSHRKDM4EBLMNPSR1 | |
| SCHEMBL21334959 | 0.78 | KMT2A (1.00) | CYP3A4TSHRKDM4EBLMNPSR1 | |
| SCHEMBL25101013 | 0.78 | KDM4E (0.64) | CYP3A4TSHRKDM4EBLMNPSR1 | |
| SCHEMBL2567149 | 0.74 | MEN1 (0.69) | CYP3A4TSHRKDM4EBLMNPSR1 | |
| SCHEMBL11598554 | 0.74 | MEN1 (0.69) | CYP3A4TSHRKDM4EBLMNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1060223-B1 | PHOTOCHROMIC COATING COMPOUND AND SUBSTRATE COATED WITH SAME | INST NEUE MAT GEMEIN GMBH (DE) | 2004-08-18 | — | — | EP | claimed |
| US-6639039-B1 | Polysiloxane precondensate having curable glycidol or methacryl functionality, dye, stabilizer and particles; light and scratch resistance | Institut für Neue Materialien Gemeinnützige GmbH (DE) | 2003-10-28 | — | — | US | claimed |
| EP-1060223-A1 | PHOTOCHROMIC COATING COMPOUND AND SUBSTRATE COATED WITH SAME | Institut Für Neue Materialien gem. GmbH (DE) | 2000-12-20 | — | — | EP | claimed |
| WO-1999041326-A1 | PHOTOCHROMIC COATING COMPOUND AND SUBSTRATE COATED WITH SAME | INSTITUT FÜR NEUE MATERIALIEN GEM. GMBH (DE) | 1999-08-19 | — | — | WO | claimed |
| US-20250205140-A1 | SURFACTANT AND COSMETIC | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-06-26 | — | — | US | disclosed |
| EP-4512872-A1 | SURFACTANT AND COSMETIC | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-02-26 | — | — | EP | disclosed |
| US-20240409517-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-12-12 | — | — | US | disclosed |
| EP-4415561-A2 | ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-08-21 | — | — | EP | disclosed |
| US-20230346831-A1 | METHODS FOR TREATING METASTATIC CANCER USING LOW DOSE CARBON MONOXIDE | CORNELL UNIVERSITY (US) | 2023-11-02 | — | — | US | disclosed |
| WO-2023062110-A2 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2023-04-20 | — | — | WO | disclosed |
| US-20220244263-A1 | METHODS FOR TREATING SMALL CELL NEUROENDOCRINE AND RELATED CANCERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-08-04 | — | — | US | disclosed |
| US-20110190351-A1 | Benzoimidazole Derivatives and Glycogen Synthase Kinase-3 Beta Inhibitors Containing the Same | ONCOTHERAPY SCIENCE, INC. (JP) | 2011-08-04 | — | — | US | disclosed |
| EP-1883534-B1 | REGENERATABLE, STRUCTURED PLATE COMPRISING OXIDATION CATALYSTS | LEIBNIZ INST NEUE MATERIALIEN (DE) | 2010-12-01 | — | — | EP | disclosed |
| WO-2010014794-A1 | BENZOIMIDAZOLE DERIVATIVES AND GLYCOGEN SYNTHASE KINASE-3 BETA INHIBITORS CONTAINING THE SAME | ONCOTHERAPY SCIENCE, INC. (JP) | 2010-02-04 | — | — | WO | disclosed |
| US-20090035703-A1 | Regeneratable, structured plate comprising oxidation catalysts | LEIBNIZ-INSTITUT FUER NEUE MATERIALIEN GEMEINNUETZIGE GMBH (DE) | 2009-02-05 | — | — | US | disclosed |
| EP-1883534-A1 | REGENERATABLE, STRUCTURED PLATE COMPRISING OXIDATION CATALYSTS | Leibniz-Institut für Neue Materialien gemeinnützige GmbH (DE) | 2008-02-06 | — | — | EP | disclosed |
| WO-2006125635-A1 | REGENERATABLE, STRUCTURED PLATE COMPRISING OXIDATION CATALYSTS | LEIBNIZ-INSTITUT FÜR NEUE MATERIALIEN GEMEINNÜTZIGE GMBH (DE) | 2006-11-30 | — | — | WO | disclosed |
| EP-1060223-B1 | PHOTOCHROMIC COATING COMPOUND AND SUBSTRATE COATED WITH SAME | INST NEUE MAT GEMEIN GMBH (DE) | 2004-08-18 | — | — | EP | disclosed |
| EP-1060223-A1 | PHOTOCHROMIC COATING COMPOUND AND SUBSTRATE COATED WITH SAME | Institut Für Neue Materialien gem. GmbH (DE) | 2000-12-20 | — | — | EP | disclosed |
| WO-1999041326-A1 | PHOTOCHROMIC COATING COMPOUND AND SUBSTRATE COATED WITH SAME | INSTITUT FÜR NEUE MATERIALIEN GEM. GMBH (DE) | 1999-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240409517-A1 | ORGANIC COMPOUNDS | HTR3C, HTR3A, H1-0 | CYP3A4 1043/4885TSHR 2055/4885KDM4E 272/4885 |
| US-20110190351-A1 | Benzoimidazole Derivatives and Glycogen Synthase Kinase-3 Beta Inhibitors Containing the Same | GSK3B, GSK3A, GYS2 | CYP3A4 1466/4885TSHR 4605/4885KDM4E 1394/4885 |
| US-20250205140-A1 | SURFACTANT AND COSMETIC | SGMS1, H1-0, SGMS2 | CYP3A4 3843/4885TSHR 1227/4885KDM4E 3645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.